TCL Archive Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board February 3, 1989
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: Appelbaum Clinical Dib. At Hutchinson; Vogelstein Win Pezcoller Award; Curiel To UAB July 23, 1993
TCL Archive ASCO Annual Report Names Significant Clinical Research Advances Of Past Year December 25, 2009
TCL Archive In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center December 7, 2012
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
